@xconomy.com 14 days ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com 10 months ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com 11 months ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com 1 year ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@techcrunch.com 1 year ago
Healthcare by 2028 will be doctor-directed, patient-owned and powered by visual technologies
@xconomy.com 1 year ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@techcrunch.com 3 years ago
Grail is raising at least $1 billion to fund its early cancer screening test